Dashboard
Manage Tickers

MVALVanEck Morningstar Wide Moa...


$ 30.75 $ -0.09 (-0.27 %)    

Thursday, 28-Mar-2024 12:04:13 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.83 $ 0.25 (0.05 %)
DIA $ 417.12 $ -0.12 (-0.03 %)
SPY $ 563.14 $ 0.23 (0.04 %)
TLT $ 100.82 $ -0.49 (-0.48 %)
GLD $ 237.35 $ -1.32 (-0.55 %)
$ 32.8232
$ 31.91 x 100
-- x --
-- - --
$ 28.89 - $ 32.97
173
na
na
$ 0.08
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

iffs-leverage-to-improve-by-2025-sales-momentum-to-boost-ebitda-projects-analyst
IFF's Leverage to Improve by 2025, Sales M...
07/22/2024 17:20:26

IFF stock upgraded to Buy with increased price target of $115. Analyst sees sales and EBITDA growth, expects leverage to decrea...

iffs-focus-on-health-and-environment-set-to-drive-stock-momentum-says-analyst
IFF's Focus On Health And Environment Set ...
06/07/2024 16:37:51

Oppenheimer initiates coverage on IFF at Outperform rating with $116 price target. Analyst sees potential for shareholder base ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION